News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sanofi-Aventis (France) to Invest $90 Million in Lantus in China
April 21, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters - Sanofi-Aventis (SASY.PA), the world's fourth-biggest drug maker, will invest $90 million to boost output of the insulin Lantus in China, the company said in a statement on Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Asia
Sanofi
MORE ON THIS TOPIC
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
·
1 min read
·
Annalee Armstrong
Deals
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks
June 24, 2026
·
2 min read
·
Tristan Manalac
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
June 24, 2026
·
2 min read
·
Annalee Armstrong
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
June 22, 2026
·
2 min read
·
Gabrielle Masson
